MY ACCOUNT | NEWSLETTER |
HOME | Companion animals | Latest News

Technavio: 4-year increase for companion animal specialty medication market

Market analysis firm, Technavio, forecasts that the companion animal specialty drug market will increase by a CAGR of 5.20% from 2021 to 2025. The market is expected to reach a value of $2.8 billion by the end of the period. Unlike other sectors, this market saw a positive impact from the COVID-19 pandemic as spending on pets increased. 

Continued momentum in the market is expected based partly on the strength of companion animal pharmaceuticals and a recent increase in vaccinations for pets. Additionally, within the companion animal marketplace, specialty medications are forecast to grow due to trends toward pets being seen as family members, increased knowledge of animal disease and prevention, increased use of companion animal insurance.

Regionally, the US market holds a significant share of the companion animal specialty drugs realm. North America is expected to account for 39% of growth.

Source: https://www.prnewswire.com/news-releases/global-companion-animal-specialty-drugs-market-growth-analysis-in-pharmaceuticals-industry--discover-company-insights-in-technavio-301339351.html


Like0
Dislike0

Comments

  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Tag

TechnavioCompanion AnimalMarket ResearchAnimal DrugsCOVID-19

Related Articles

19 August 2022

Animal pregnancy test market to approach 5%
22 June 2022

Vet US market to surpass 5% growth

06 May 2022

Pig vaccine market to exceed 7% growth
27 April 2022

Animal pregnancy tests to approach 5% growth
01 April 2022

Veterinary scales market to grow by 7.40%

More news

Scheduled Events Events

WVAC 2024 - April 16-19, Cape Town

Read more
Like1
Dislike0

Latest News Veterinary News

Interview With Dr. Anthony Pease

Read more
Like0
Dislike0

Latest News Public health

Human exposures to Brucella canis from a pregnant dog during an international flight: Public health risks, diagnostic challenges, and future considerations

Read more
Like0
Dislike0

Latest News Companion animals

Efficacy of antimicrobial and nutraceutical treatment for canine acute diarrhoea

Read more
Like0
Dislike0

Latest News Ruminants

Evaluation of the clinical efficacy of racecadotril in the treatment of neonatal calves with infectious diarrhea.

Read more
Like0
Dislike0

Newsletter

 
 

News of interest

WVAC 2024 - April 16-19, Cape Town
Interview With the SignalPET Team
Canine Lymphoma Diagnosis, Treatment, and Research
New Study Examines How Dog Size Influences Disease Risk

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

About Us Authors Contact Us Legal Notes Privacy Search

Top